2 active not recruiting. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Active not recruiting 2 |
Follow Hyperglycemia: new trials by email Literature Review of Hyperglycemia trials Research Report on Hyperglycemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Early Hydrocortisone Versus Regular Treatment in Shock in Extremely Preterm Neonates - an Open Randomized Controlled Trial Intravascular Hydrocortisone (stress dosage): 1 mg/k/dose each 8 hours for 5 days, Vasoactive drug therapies - Shock, Preterm Birth Complication | Phase 4 | Active not recruiting | Coordinación de Investigación en Salud, Mexico | 76 | 2025-02-01 | 2025-11-25 |
| The Renin-Angiotensin-Aldosterone System in Adiposity, Blood Pressure and Glucose in African Americans Sacubitril-Valsartan Tab 97-103 MG, Valsartan 160mg, Placebo Oral Tablet - PreDiabetes, Impaired Glucose Tolerance | Phase 4 | Active not recruiting | Ohio State University | 90 | 2020-02-25 | 2025-08-11 |
Enterocolitis, Necrotizing (1) · Glucose Intolerance (1) · Intestinal Perforation (1) · Neonatal Sepsis (1) · Obesity (1) · Prediabetic State (1) · Pulmonary Atelectasis (1) · Shock (1)
Glucose Metabolism Disorders (2) · Metabolic Diseases (2) · Nutritional and Metabolic Diseases (2) · Pathological Conditions, Signs and Symptoms (2) · Body Weight (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Diabetes Mellitus (1) · Digestive System Diseases (1) · Endocrine System Diseases (1) · Enterocolitis (1) · Gastroenteritis (1) · Gastrointestinal Diseases (1) · Infant, Newborn, Diseases (1) · Infections (1)
Valsartan (1) · sacubitril and valsartan sodium hydrate drug combination (1)
Coordinación de Investigación en Salud, Mexico (1) · Ohio State University (1)
Mexico (1) · United States (1)
K23DK117041 (1)